Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078902214> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2078902214 endingPage "289" @default.
- W2078902214 startingPage "286" @default.
- W2078902214 abstract "The use of TNF-alpha antagonists may be associated with an increased rate of infections in risk populations of patients with RA. Our hypothesis was that in patients with a high risk of infection Rituximab (RTX) could be a safer alternative.We analyzed the outcome of RA patients who received RTX instead of TNF-alpha antagonist because of a history of serious infections or frequent infectious events. All patients in a given time period were included in the retrospective analysis.32 patients were identified according to the above criteria and followedup for a mean period of 16 ± 8 months (range 6 - 36) during treatment with RTX. Only one patient was lost to follow-up. Sixteen patients were anti-TNF-naïve and in the remaining patients the TNF-alpha antagonist was stopped due to infectious complications before starting RTX. RTX was combined with a disease modifying drug in 22 (69%) of the cases. Altogether 4 severe infections occurred (9.5/100 patient years), mainly within the first year of treatment with RTX. Two patients suffered from pneumonia, 1 from a postoperative wound infection, 1 from an ear abscess and bacterial bronchitis. None of our patients with a previous history of bacterial infections of soft tissue, bacterial arthritis or osteomyelitis (n=9) developed recurrent infection. No relapse of a previously diagnosed tuberculosis (n=9) was seen.In this particular high risk population of RA patients, treatment with RTX seems to be an alternative to TNF-alpha-antagonist and has a relatively low rate of recurrent infection." @default.
- W2078902214 created "2016-06-24" @default.
- W2078902214 creator A5018678232 @default.
- W2078902214 date "2012-09-07" @default.
- W2078902214 modified "2023-10-18" @default.
- W2078902214 title "Rituximab (RTX) as an Alternative to TNF-Alpha Antagonists in Patients with Rheumatoid Arthritis and High Risk of Severe Infections: A Systematic Analysis of the Experience in One Center" @default.
- W2078902214 cites W1963651539 @default.
- W2078902214 cites W1967360492 @default.
- W2078902214 cites W2046549669 @default.
- W2078902214 cites W2078595150 @default.
- W2078902214 cites W2106997293 @default.
- W2078902214 cites W2115018403 @default.
- W2078902214 cites W2136215457 @default.
- W2078902214 cites W2152973730 @default.
- W2078902214 cites W2167404036 @default.
- W2078902214 doi "https://doi.org/10.2174/1874312901206010286" @default.
- W2078902214 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3447167" @default.
- W2078902214 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23002410" @default.
- W2078902214 hasPublicationYear "2012" @default.
- W2078902214 type Work @default.
- W2078902214 sameAs 2078902214 @default.
- W2078902214 citedByCount "15" @default.
- W2078902214 countsByYear W20789022142013 @default.
- W2078902214 countsByYear W20789022142014 @default.
- W2078902214 countsByYear W20789022142015 @default.
- W2078902214 countsByYear W20789022142016 @default.
- W2078902214 countsByYear W20789022142017 @default.
- W2078902214 countsByYear W20789022142018 @default.
- W2078902214 countsByYear W20789022142020 @default.
- W2078902214 crossrefType "journal-article" @default.
- W2078902214 hasAuthorship W2078902214A5018678232 @default.
- W2078902214 hasBestOaLocation W20789022141 @default.
- W2078902214 hasConcept C126322002 @default.
- W2078902214 hasConcept C141071460 @default.
- W2078902214 hasConcept C2777575956 @default.
- W2078902214 hasConcept C2777914695 @default.
- W2078902214 hasConcept C2779338263 @default.
- W2078902214 hasConcept C2780653079 @default.
- W2078902214 hasConcept C2908647359 @default.
- W2078902214 hasConcept C71924100 @default.
- W2078902214 hasConcept C99454951 @default.
- W2078902214 hasConceptScore W2078902214C126322002 @default.
- W2078902214 hasConceptScore W2078902214C141071460 @default.
- W2078902214 hasConceptScore W2078902214C2777575956 @default.
- W2078902214 hasConceptScore W2078902214C2777914695 @default.
- W2078902214 hasConceptScore W2078902214C2779338263 @default.
- W2078902214 hasConceptScore W2078902214C2780653079 @default.
- W2078902214 hasConceptScore W2078902214C2908647359 @default.
- W2078902214 hasConceptScore W2078902214C71924100 @default.
- W2078902214 hasConceptScore W2078902214C99454951 @default.
- W2078902214 hasIssue "1" @default.
- W2078902214 hasLocation W20789022141 @default.
- W2078902214 hasLocation W20789022142 @default.
- W2078902214 hasLocation W20789022143 @default.
- W2078902214 hasLocation W20789022144 @default.
- W2078902214 hasOpenAccess W2078902214 @default.
- W2078902214 hasPrimaryLocation W20789022141 @default.
- W2078902214 hasRelatedWork W2045151582 @default.
- W2078902214 hasRelatedWork W2082406232 @default.
- W2078902214 hasRelatedWork W2156283049 @default.
- W2078902214 hasRelatedWork W2316954211 @default.
- W2078902214 hasRelatedWork W2326094713 @default.
- W2078902214 hasRelatedWork W2427075784 @default.
- W2078902214 hasRelatedWork W2617939361 @default.
- W2078902214 hasRelatedWork W2761967325 @default.
- W2078902214 hasRelatedWork W4210646529 @default.
- W2078902214 hasRelatedWork W4238056209 @default.
- W2078902214 hasVolume "6" @default.
- W2078902214 isParatext "false" @default.
- W2078902214 isRetracted "false" @default.
- W2078902214 magId "2078902214" @default.
- W2078902214 workType "article" @default.